Document is current
Any future updates will be listed below
-
Authors
Zhang, Peixin
Hu, Jiali
Li, Mengyao
Zhang, Hongxia
-
Funding
Funding for this research was provided by:
2023 Annual Corps Guiding Science and Technology Plan Project of Shihezi University (Project No. 2023ZD021)
National Natural Science Foundation of China (Grant No. 81860374)
The 2021 University-Level Scientific Research Project Independently Supported by Shihezi University (Grant No. ZZZC202186)
- License Information
-
More Information
Article History
Received: 23 November 2025
Accepted: 6 April 2026
First Online: 25 April 2026
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee (approval number 2203) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This study was approved by the Ethics Committee of Science and Technology of The First Affiliated Hospital of Shihezi University (Approval No. KJ2024-262-01) on 12 June 2024.The patient has provided consent for anonymous publication of this case to contribute to medical advancement. Written informed consent was obtained from all individual participants or for minors, from their legal guardians prior to their inclusion in the study.
: All authors have read and approved the final version of this manuscript and consent to its publication in Discover Oncology. The manuscript does not contain any individual person’s identifiable data, images, or clinical details.
: The authors declare no competing interests.
